All In Biotech

Drug Trial Radar · NCT06700720

YN001-004 in Patients With Coronary Atherosclerosis in Australia

A Phase Ⅱa Clinical Study to Evaluate the Efficacy and Safety of YN001 in Patients With Coronary Atherosclerosis in Australia

Last checked: Nov 19, 2026Latest source record: Sep 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

3

Actual

Start

Feb 25, 2026

Primary completion

Jul 22, 2026

Study completion Jul 22, 2026

Sponsor

Sponsor type
Industry
First posted
Nov 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is to evaluate the efficacy and safety of intravenously administered YN001 in patients with coronary atherosclerosis in Australia. This study will be conducted in eligible participants with a diagnosis of coronary atherosclerosis, and at least 1 coronary artery is blocked determined by coronary computed tomography angiography (CCTA)

Conditions

  • Coronary Artery Disease
  • Coronary Atherosclerotic Disease

Interventions

  • Dose 1 YN001Drug

    Dose 1 YN001 will be administered on Day 1 of each week from Week 1 to Week 13, 13 times in total.

  • Dose 2 YN001Drug

    Dose 2 YN001 will be administered on Day 1 of each week from Week 1 to Week 13, 13 times in total.

  • EvolocumabDrug

    Evolocumab 140 mg will be administered subcutaneously every 2 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes in coronary plaque characteristics (volume and composition)Time frame: From baseline to Week 13

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • John Flynn Private Hospital

    Tugun, Australia

  • Canberra Hospital

    Canberra, Australian Capital Territory, Australia

  • Albury Wodonga Private Hospital

    Albury, New South Wales, Australia

  • Sunshine Coast University Private Hospital

    Birtinya, Queensland, Australia

  • Altona Clinical Research

    Melbourne, Victoria, Australia

  • Peninsula Heart Centre

    Melbourne, Victoria, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.